NCT01697527 2025-11-24
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT02130492 2025-10-23
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Weill Medical College of Cornell University
Phase 1/2 Suspended
NCT06956391 2025-06-04
Ultralow Dose PET Imaging of 18F-FDG Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT01246869 2024-10-01
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
University of Utah
Phase 1 Terminated
NCT06424873 2024-05-22
Dynamic PET/CT
University Hospital, Geneva
Phase NA Recruiting
NCT01243333 2024-04-17
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Phase NA Terminated
NCT00708045 2024-03-15
Chemobrain
University of Utah
Phase 1 Completed
NCT05506566 2023-09-21
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies
First Affiliated Hospital of Fujian Medical University
Phase 1/2 Unknown
NCT00813566 2022-04-27
Multi-Tracer PET Assessment of Primary Brain Tumors
University of Utah
Phase 1 Completed
NCT03107325 2020-10-06
Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging
Boston Children's Hospital
Phase 4 Withdrawn
NCT02287636 2020-02-24
PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT01180751 2013-08-15
18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
University of Manitoba
Phase 3 Unknown
NCT00001568 2008-03-04
Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities
National Institutes of Health Clinical Center (CC)
Phase 2 Completed